肺高血压的雾化吸入治疗  

Inhalation Therapy for Pulmonary Hypertension

作　　者：刘璐[1] 周章兵[1] 王华[1] 

机构地区：[1]昆明医科大学第一附属医院呼吸一科,昆明650032

出　　处：《医学综述》2013年第11期1992-1994,共3页Medical Recapitulate

摘　　要：肺高血压是以肺动脉压力增高,伴或不伴小肺动脉病变为特征的恶性肺血管疾病,为临床常见征象,治疗措施较多,其中雾化吸入直接作用于病变肺血管,选择性更高,可减少用药量及全身不良反应。雾化吸入降低肺高血压的药物主要有一氧化氮供体、依前列醇类以及研究较少的肝素类药物。该文就与呼吸系统疾病相关的肺高血压雾化吸入治疗的临床应用进展予以综述。Pulmonary hypertension is a malignant pulmonary vascular disease ,leatured with mcreased pulmo- nary artery pressure, accompanied with/without small pulmonary artery lesion, which are commonly seen in clini- cal ,and the treatment is various. Aerosol inhalation directly acts on pulmonary vaseular lesions with higher selec- tivity,less medication dosage and systemic asdverse effects. NO donor, PGI2, and the less studied heparin are the main drugs to reduce pulmonary hypertension. Here is to make a review of the clinical application progress of PH inhalation treatment for resoirato~ diseases,

关 键 词：肺高血压 雾化吸入 药物 

分 类 号：R563.9[医药卫生—呼吸系统]